Ventricular Catheters, Thomale Catheter
AESCULAP, INC. · Decision date Oct 2, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 02 October 2026 for K260044, a traditional 510(k) from Aesculap, Inc. of Center Valley, Pennsylvania, covering Ventricular Catheters, Thomale Catheter. The device falls under regulation 882.5550, classification name Shunt, Central Nervous System And Components, with primary product code JXG and subsequent product code HCA; the regulation medical specialty and review panel are both Neurology. The application was received 01 January 2026 and was not reviewed by a third party.
SESE means the submission was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record lists no combination product and no authorized predetermined change control plan, and the source provides no summary statement, so the specific predicate device, the components or modifications assessed, and any performance data remain unknown. The same FDA final-decisions listing dated 02 October 2026 also records K261741 and K260064, which are separate applications unrelated to this one.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Oct 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260044
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- AESCULAP, INC.
- Product code
- JXG
- Decision code
- SESE
- Decision date
- Oct 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Shunt, Central Nervous System And Components.
- Applicant
- AESCULAP, INC.
- Product code
- JXG
- FDA device class
- 2
FDA decision timeline
K260044 received
Application receipt date recorded by FDA.
K260044 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
AESCULAP, INC.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Center Valley, PA
Sources and methodology
- Original FDA record: K260044
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records